Kenneth A Kobak

Summary

Affiliation: Dean Health System
Country: USA

Publications

  1. ncbi request reprint St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study
    Kenneth A Kobak
    Dean Foundation for Health Research and Education, Middleton, Wisconsin 53562, USA
    Int Clin Psychopharmacol 20:299-304. 2005
  2. ncbi request reprint Prevalence and burden of illness of migraine in managed care patients
    Kenneth A Kobak
    Dean Foundation for Health Education and Research, 2711 Allen Blvd, Middleton, WI 53562, USA
    J Manag Care Pharm 11:124-36. 2005
  3. ncbi request reprint St. John's wort versus placebo in social phobia: results from a placebo-controlled pilot study
    Kenneth A Kobak
    Dean Foundation for Health Research and Education, Middleton, WI, USA
    J Clin Psychopharmacol 25:51-8. 2005
  4. ncbi request reprint Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study
    Kenneth A Kobak
    Dean Foundation for Health, Research and Education, Middleton, Wisconsin, USA
    J Clin Psychopharmacol 22:257-62. 2002
  5. doi request reprint Sources of unreliability in depression ratings
    Kenneth A Kobak
    MedAvante Research Institute, Madison, WI, USA
    J Clin Psychopharmacol 29:82-5. 2009
  6. ncbi request reprint Antidepressant medication management and Health Plan Employer Data Information Set (HEDIS) criteria: reasons for nonadherence
    Kenneth A Kobak
    Dean Foundation for Health, Research and Education, 2711 Allen Blvd, Middleton, WI 53562, USA
    J Clin Psychiatry 63:727-32. 2002
  7. ncbi request reprint PANSS rater training using Internet and videoconference: results from a pilot study
    Kenneth A Kobak
    MedAvante, Inc, 7601 Ganser Way, Madison, WI 53719, USA
    Schizophr Res 92:63-7. 2007
  8. ncbi request reprint A novel approach to rater training and certification in multinational trials
    Elizabeth Jeglic
    MedAvante Research Institute, Ganser Way, Madison, Wisconsin 53719, USA
    Int Clin Psychopharmacol 22:187-91. 2007
  9. ncbi request reprint Cost-effectiveness of computer-aided behaviour therapy for obsessive-compulsive disorder
    Paul McCrone
    Psychother Psychosom 76:249-50. 2007
  10. ncbi request reprint Are the effects of rater training sustainable? Results from a multicenter clinical trial
    Kenneth A Kobak
    J Clin Psychopharmacol 27:534-5. 2007

Detail Information

Publications21

  1. ncbi request reprint St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study
    Kenneth A Kobak
    Dean Foundation for Health Research and Education, Middleton, Wisconsin 53562, USA
    Int Clin Psychopharmacol 20:299-304. 2005
    ..9%) and placebo (16.7%) (P=0.905). Only one patient from each group discontinued due to adverse events [sinus infection (St John's wort); confusion (placebo)]. The results fail to support the efficacy of St John's wort for OCD...
  2. ncbi request reprint Prevalence and burden of illness of migraine in managed care patients
    Kenneth A Kobak
    Dean Foundation for Health Education and Research, 2711 Allen Blvd, Middleton, WI 53562, USA
    J Manag Care Pharm 11:124-36. 2005
    ..maintenance organization (HMO) population, using a 2-stage screening process and neurologist exam, and to examine the burden of illness associated with both previously diagnosed and previously undiagnosed migraine in this population..
  3. ncbi request reprint St. John's wort versus placebo in social phobia: results from a placebo-controlled pilot study
    Kenneth A Kobak
    Dean Foundation for Health Research and Education, Middleton, WI, USA
    J Clin Psychopharmacol 25:51-8. 2005
    ..Results of the study fail to provide evidence for the efficacy of SJW in social phobia. The impact of methodologic improvements on signal detection, while suggestive of improvement, remains to be established...
  4. ncbi request reprint Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study
    Kenneth A Kobak
    Dean Foundation for Health, Research and Education, Middleton, Wisconsin, USA
    J Clin Psychopharmacol 22:257-62. 2002
    ..Fluoxetine failed to separate from placebo in this trial. It is unknown whether a larger dose for longer duration would have yielded separation from placebo. A higher than usual placebo response rate was found...
  5. doi request reprint Sources of unreliability in depression ratings
    Kenneth A Kobak
    MedAvante Research Institute, Madison, WI, USA
    J Clin Psychopharmacol 29:82-5. 2009
    ..We videotaped and transcribed 30 pairs of interviews to examine the most common sources of rater unreliability...
  6. ncbi request reprint Antidepressant medication management and Health Plan Employer Data Information Set (HEDIS) criteria: reasons for nonadherence
    Kenneth A Kobak
    Dean Foundation for Health, Research and Education, 2711 Allen Blvd, Middleton, WI 53562, USA
    J Clin Psychiatry 63:727-32. 2002
    ..We examined the reasons for this failure through a systematic chart review...
  7. ncbi request reprint PANSS rater training using Internet and videoconference: results from a pilot study
    Kenneth A Kobak
    MedAvante, Inc, 7601 Ganser Way, Madison, WI 53719, USA
    Schizophr Res 92:63-7. 2007
    ..The use of these technologies allows for training to be more effectively delivered to diverse sites in multi-center trials, and for evaluation of raters' applied clinical skills, an area that has previously been overlooked...
  8. ncbi request reprint A novel approach to rater training and certification in multinational trials
    Elizabeth Jeglic
    MedAvante Research Institute, Ganser Way, Madison, Wisconsin 53719, USA
    Int Clin Psychopharmacol 22:187-91. 2007
    ..25 to 11.31, P=0.003. These results support the efficacy of this applied training model in improving raters' applied clinical skills in multinational trials...
  9. ncbi request reprint Cost-effectiveness of computer-aided behaviour therapy for obsessive-compulsive disorder
    Paul McCrone
    Psychother Psychosom 76:249-50. 2007
  10. ncbi request reprint Are the effects of rater training sustainable? Results from a multicenter clinical trial
    Kenneth A Kobak
    J Clin Psychopharmacol 27:534-5. 2007
  11. doi request reprint Development and reliability of a structured interview guide for the Montgomery Asberg Depression Rating Scale (SIGMA)
    Janet B W Williams
    Biometrics Research Unit, Columbia University, New York, New York, USA
    Br J Psychiatry 192:52-8. 2008
    ..Structured and semi-structured interview guides have been found to improve reliability with other scales...
  12. doi request reprint The GRID-HAMD: standardization of the Hamilton Depression Rating Scale
    Janet B W Williams
    Columbia University, New York, NY, USA
    Int Clin Psychopharmacol 23:120-9. 2008
    ..Overall, these data suggest that the GRID-HAMD is an improvement over the original Guy version as well as the SIGH-D in its incorporation of innovative features and preservation of high reliability and validity...
  13. ncbi request reprint Rating the raters: assessing the quality of Hamilton rating scale for depression clinical interviews in two industry-sponsored clinical drug trials
    Nina Engelhardt
    MedAvante, Inc MedAvante, Ewing, NJ, USA
    J Clin Psychopharmacol 26:71-4. 2006
    ..We evaluated the quality of Hamilton Rating Scale for Depression (HAM-D) clinical interviews performed at baseline in 2 similar multicenter, randomized, placebo-controlled depression trials sponsored by 2 pharmaceutical companies...
  14. ncbi request reprint Why the Hamilton Depression Rating Scale endures
    Per Bech
    Am J Psychiatry 162:2396; author reply 2397-8. 2005
  15. ncbi request reprint A new approach to rater training and certification in a multicenter clinical trial
    Kenneth A Kobak
    MedAvante Inc, 7601 Ganser Way, Madison, WI 53719, USA
    J Clin Psychopharmacol 25:407-12. 2005
    ..00 to 11.00, P = 0.033. Three raters failed all 3 attempts and were excluded from the study. Results support the efficacy of the approach in improving both conceptual knowledge and applied interviewing skill...
  16. ncbi request reprint Interview quality and signal detection in clinical trials
    Kenneth A Kobak
    Am J Psychiatry 162:628. 2005
  17. ncbi request reprint A comparison of face-to-face and videoconference administration of the Hamilton Depression Rating Scale
    Kenneth A Kobak
    Research Training Associates and MedAvante, Madison, Wisconsin 53719, USA
    J Telemed Telecare 10:231-5. 2004
    ..The study shows the psychometric equivalence of remote and face-to-face HAMD administration...
  18. ncbi request reprint Development of a standardized training program for the Hamilton Depression Scale using internet-based technologies: results from a pilot study
    Kenneth A Kobak
    Research Training Associates, Madison, WI 53719, USA
    J Psychiatr Res 37:509-15. 2003
    ..97, P<0.0001. Results support the feasibility of this methodology for improving rater training. An NIMH funded study is currently underway examining this methodology in a multi-site trial...
  19. ncbi request reprint St. John's wort in generalized anxiety disorder: three more case reports
    Kenneth A Kobak
    J Clin Psychopharmacol 23:531-2. 2003
  20. ncbi request reprint Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial
    David Mataix-Cols
    Department of Psychiatry, Imperial College School of Medicine, London, UK
    Psychother Psychosom 71:255-62. 2002
    ..This study examined whether previously identified OCD symptom dimensions are associated with treatment compliance and response to behaviour therapy (BT) for OCD...
  21. ncbi request reprint Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control
    John H Greist
    Healthcare Technology Systems, and the University of Wisconsin, Madison, 53717, USA
    J Clin Psychiatry 63:138-45. 2002
    ..This study compared the value of computer-guided behavior therapy value with that of clinician-guided behavior therapy and systematic relaxation as a control treatment...